DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor-like polypeptides
US4874743A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Mar 15, 1985 |
| Grant date | Oct 17, 1989 |
| Priority date | — |
| Expiry date | Mar 15, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
DNA sequences, recombinant DNA molecules and hosts transformed with them which produce human phospholipase inhibitor-like polypeptides and methods of making and using these products. The DNA sequences and recombinant DNA molecules are characterized in that they code on expression for a human phospholipase inhibitor-like polypeptide. In appropriate hosts these DNA sequences permit the production of human phospholipase inhibitor-like polypeptides useful as anti-inflammatory agents and methods in the treatment of arthritic, allergic, dermatologic, ophthalmic and collagen diseases as well as other disorders involving inflammatory processes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.